Edesa Biotech Inc (EDSA)
4.58
+0.27
(+6.26%)
USD |
NASDAQ |
Apr 25, 12:58
Edesa Biotech Cash and Short Term Investments (Quarterly): 4.268M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.268M |
September 30, 2023 | 5.361M |
June 30, 2023 | 6.457M |
March 31, 2023 | 7.471M |
December 31, 2022 | 8.270M |
September 30, 2022 | 7.091M |
June 30, 2022 | 12.81M |
March 31, 2022 | 15.89M |
December 31, 2021 | 5.881M |
September 30, 2021 | 7.839M |
June 30, 2021 | 8.053M |
March 31, 2021 | 10.97M |
December 31, 2020 | 6.305M |
September 30, 2020 | 7.214M |
June 30, 2020 | 5.641M |
March 31, 2020 | 6.990M |
December 31, 2019 | 4.327M |
June 30, 2019 | 6.363M |
March 31, 2019 | 7.684M |
December 31, 2018 | 8.964M |
September 30, 2018 | 10.30M |
June 30, 2018 | 11.28M |
March 31, 2018 | 3.793M |
December 31, 2017 | 5.368M |
September 30, 2017 | 6.565M |
Date | Value |
---|---|
June 30, 2017 | 7.645M |
March 31, 2017 | 8.596M |
December 31, 2016 | 9.879M |
September 30, 2016 | 11.41M |
June 30, 2016 | 6.786M |
March 31, 2016 | 7.961M |
December 31, 2015 | 8.904M |
September 30, 2015 | 8.971M |
June 30, 2015 | 10.16M |
March 31, 2015 | 11.15M |
December 31, 2014 | 12.76M |
August 31, 2014 | 13.89M |
May 31, 2014 | 14.79M |
February 28, 2014 | 15.84M |
November 30, 2013 | 16.84M |
August 31, 2013 | 7.860M |
May 31, 2013 | 1.789M |
February 28, 2013 | 0.9218M |
November 30, 2012 | 1.632M |
August 31, 2012 | 0.999M |
May 31, 2012 | 1.954M |
February 29, 2012 | 2.946M |
November 30, 2011 | 4.076M |
August 31, 2011 | 4.146M |
May 31, 2011 | 5.099M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.268M
Minimum
Dec 2023
15.89M
Maximum
Mar 2022
7.622M
Average
7.040M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Acasti Pharma Inc | 25.11M |
Aurinia Pharmaceuticals Inc | 350.49M |
Lexaria Bioscience Corp | 4.793M |
Xenon Pharmaceuticals Inc | 638.08M |
ESSA Pharma Inc | 142.12M |